When Is Medication Uniformity Not Really Uniformity?
Tom LaMarra
February 3, 2014
Stakeholders are learning how difficult it can be to achieve uniformity, even with basic regulations.
Stakeholders are learning how difficult it can be to achieve uniformity, even with basic regulations.
Industry stakeholders met Jan. 30 for an update on adoption of uniform medication and drug testing rules.
Officials will soon consider a penalty system for drug violations that dovetails with uniform model rules.
Officials heard the pros and cons of having different medication rules for Thoroughbreds and Standardbreds.
A barn was quarantined due to a suspected EHV case, but quickly released when the horse tested negative.
The quarantine of two barns began in early November 2013 when a horse tested positive for EHV-1.
The study indicates indicates a large percentage of horses are acquired from their owners, not auctions.
The booklet lists 24 therapeutic medications with their withdrawal times and threshold levels.
More than 20 accredited racehorse retirement facilities will share in $1 million in grants.
Out-of-competition drug testing has broad support, but some issues have made use difficult for regulators
The Ohio State Racing Commission indicated it’s not prepared to adopt a uniform national drug policy.
The Kentucky Equine Drug Research Council (KEDRC), on a 4-2 vote Dec. 3, recommended the Kentucky Horse Racing Commission (KHRC) adopt the national uniform medication rules for Thoroughbred racing.
Two barns at Parx Racing are under quarantine as a result of a positive test for equine herpesvirus.
The United States Trotting Association (USTA) has created its own Medication Advisory Committee.
Breeders’ Cup believes it is prepared in the areas of horse safety and security for the World Championships.
The Massachusetts Gaming Commission voted unanimously to adopt uniform medication and drug-testing rules.
Stay on top of the most recent Horse Health news with
